NF1 and malignant peripheral nerve sheath tumor: Subjects with NF1 have an increased oncogenic risk, including juvenile myelomonocytic leukemia, rhabdomyosarcoma, malignant peripheral nerve sheath tumor and non-invasive pilocytic astrocytoma, particularly OPG (131).